Thursday 30 May 2019

Multiple Sclerosis Treatment Market to Perceive a Substantial Growth with approx. 3.5% CAGR during 2017-2023; MRFR Unleashes Insights up to 2023

Market Synopsis
Market Research Future postulates that the global multiple sclerosis treatment market is estimated to demonstrate 3.5% CAGR throughout the forecast period (2017-2023). Factors such as increasing patient pool and screening for better treatment options are likely to favor the market growth worldwide. Multiple sclerosis is referred to as an inflammatory, chronic, and an autoimmune disease which generally affects the central nervous system. It especially affects the communication between the brain and other body parts. Multiple sclerosis is a demyelinating disease in which the insulating covers of the nerve cells in the spinal cord and brain are damaged.
Get a FREE Sample Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/940
Market Potential and Pitfalls
Multiple sclerosis treatment market is anticipated to expand at a healthy CAGR throughout the forecast period owing to several driving factors. With augmenting patient population across the world and the need for better treatment options and greater screening, the market for multiple sclerosis treatment is estimated to flourish. As the aging population is more susceptible to the disease, the market is flourishing with the increasing geriatric population. Research and development activities are also considered to yield benefits with huge gain for the market. For instance, the introduction of a new drug with partial curing rate is expected to be welcomed by the market with minimum marketing efforts and cost. Such efforts are estimated to contribute to the market growth. Furthermore, with the augmenting incidences of muscle weakness, the market is likely to flourish in the coming years. Additional factor promoting the market growth is the presence of high unmet clinical requirements, especially in the developing economies. Organizations across the globe are spreading awareness related to progressive multiple sclerosis coupled with the symptoms associated with it, which is further estimated to propel the market growth. With reimbursement programs, the penetration of multiple sclerosis drugs is also likely to augment, thereby contributing to the market growth.
On the contrary, a significant gap between the early diagnosis and actual initiation of the therapy is likely to remain a major concern impeding the market growth to a great extent. Additionally, lack of cure and effective treatment is considered as one of the major drawbacks of the current treatment scenario. The high cost of the treatment is also presumed to impede the market growth to a large extent.

Browse Complete Report with Niche Segments and Top Industry Players at https://www.marketresearchfuture.com/reports/multiple-sclerosis-treatment-market-940
Global Multiple Sclerosis Treatment Market: Segmental Analysis
The global multiple sclerosis treatment market has been segmented on the basis of drug type, route of administration, diagnosis, and end-users.
By mode of drug type, the global multiple sclerosis treatment market has been segmented into immunosuppressant, immunomodulators, and others.
By mode of the route of administration, the global multiple sclerosis treatment market has been segmented into oral, injectable, and others.
By mode of diagnosis, the global multiple sclerosis treatment market has been segmented into simple electrical stimulation tests, magnetic resonance imaging (MRI) scans, lumbar puncture and others.
By mode of end-users, the global multiple sclerosis treatment market has been segmented into clinics, hospitals, and others.
Regional Insights
Geographically, the multiple sclerosis treatment market spans across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.
Among all the regions, America is considered to occupy the largest market share owing to the presence of U.K. in this region. U.S. is estimated to dominate the market due to the increasing R&D activities for better treatment of the disease and extensive development in the medical sector. An increasing number of hospitalization procedures owing to healthcare penetration in Canada and the U.S. are estimated to propel the market growth. Additional factors influencing the market growth are the high concentration of key hospitals and good reimbursement rates.
European is presumed to occupy the second largest market share and is likely to retain its dominance over the years. The growth is credited to the augmenting healthcare industry along with healthcare penetration. The region is mainly led by economies like France and Germany, where Germany is considered to be the fastest growing region due to the presence of its large pharmaceutical industry.
The Asia Pacific is anticipated to expand at a rapid pace and is presumed to lead the market owing to the large unmet needs coupled with the fast-developing healthcare sector in this region. South East Asian economies like India, China, and Malaysia highly contribute to the market growth. Additionally, penetration of the healthcare sector is likely to fuel the future multiple sclerosis market.
Industry Updates
January 16, 2019: In a clinical trial of Northwestern University Feinberg School of Medicine, researchers had found that while most of the patients on standard therapy were showing progression, the vast majority of patients who already underwent the stem cell transplant did not. An experimental treatment which was conducted for multiple sclerosis is now showing promise. A new study had found that a single stem cell transplant delays or stop the symptoms better than some medications.
Competitive Dashboard
The prominent players operating the global multiple sclerosis treatment market are Pfizer Inc. (U.S.), AbbVie (U.S.), Teva Pharmaceuticals (Israel), Merck (U.S.), Bayer Healthcare (Germany), Novartis (Switzerland), Sanofi Aventis (France), and Biogen Idec (U.S.).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Flow Cytometryt Market Size is Register at 11.5% CAGR to Reach by 2023


Flow Cytometry Market in diagnostics and increasing applications of flow cytometry in pharmaceutical research and development are the major factors driving the growth of the global flow cytometry market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market.
Flow Cytometry Market by increasing applications in healthcare along with the increasing number of cancer cases is projected to boost the market growth at a healthy CAGR of ~ 11.5 %.

For instance, in January 2016, Sysmex America Inc. has introduced New CyFlow monoclonal antibodies in the market, this new reagent was introduced in the American market which will be available for use in academic as well as clinical research and commercial manufacturing.

The global flow cytometry market has been segmented on the basis of products & services, technology, application, and end-user.
On the basis of products & services, the market has been classified as reagents and consumables, flow cytometry instruments, services, software, and accessories. The flow cytometry instruments segment has been further divided into cell analyzers and cell sorters.
Avail Sample Copy of this Report at: https://www.marketresearchfuture.com/sample_request/6433
The market by technology has been divided into cell-based flow cytometry and bead-based flow cytometry.
 The application segment has been divided into research applications, clinical applications, and industrial applications. The research applications segment has been segmented into pharmaceutical and biotechnology and immunology. The pharmaceutical and biotechnology sub-segment has been divided into drug discovery, stem cell research, and in vitro toxicity testing.
Furthermore, the immunology segment has been sub-segmented into cell sorting, apoptosis, cell cycle analysis, cell viability, cell counting, and other research applications. The clinical applications segment includes cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications.
Geographical Segmentation by Regions are as follows, Americas is expected to dominate the global flow cytometry market during the forecast period owing to the technological advancement, increasing prevalence of autoimmune diseases, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to the increasing number of cancer patients in the region and government funding and support of the healthcare sector.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing awareness about healthcare, increasing research and development activities and favorable government initiatives for the establishment of healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global flow cytometry market.
Some of the key players in the flow cytometry are Beckman Coulter, Inc., Becton, Dickinson and Company., Danaher., Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Partec GmbH Agilent Technologies, Inc., Sony Corporation, Biomérieux S.A., and Enzo Biochem Inc.
The high costs associated with flow cytometry instruments and reagents, lack of awareness about applications of flow cytometry and a shortage of technicians may hamper the growth of the market during the assessment period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312


Posted by at No comments:
Labels: , , , ,

Wearable Sensors Market Supply, Demand, Futuristic Cost, Revenue Research Report Forecast 2019 To 2020

Market Synopsis
Global Wearable Sensors Market is anticipated to expand at a significant rate over the assessment period (2017-2020), as per a new report by Market Research Future (MRFR). Owing to the increasing health consciousness and personal care for tracking biometrics like heart rate, calories burnt, and others, the demand for such wearable devices are increasing at a rapid pace. Wearable sensors facilitate both biological and physiological sensing and are incorporated into fashion accessories and garments like wristbands, shoes, socks, hats, headphones, eyeglasses, and several others to suit the need of the user. Several technology and gadget providers offer customization to products to attract the young crowd.


Drivers and Challenges Affecting the Market Growth
With continuously evolving sensor technology and growing demand for wearables for infants is driving the market growth. Besides, rapid expansion of Internet of Things (IoT) is driving the market in several application areas like fitness, healthcare, consumer electronics, and others. The market is gaining prominence due to technological advancements over the assessment period.
With the rising demand for compact wearables, sensor manufacturing and miniaturization have gained popularity. The                 motion-sensing capacity that can record and track movement is a major factor driving the growth of the market. Moreover, with the presence of key players like Google, Apple, Microsoft, and Samsung, the market is expected to boom in the years to come. With the usage of smart electronic devices like smartphones and tablets, monitoring and gathering of data have been made easy as these sensors can be paired with other devices which are expected to boost the market growth. Also, strict mandates regarding data storage are affecting the market positively.
Meanwhile, privacy concerns, high cost, and data integrity associated with wearable sensors are expected to hinder the market growth. Lack of responsiveness and awareness of consumers about benefits of such devices might hamper the market growth. Also, lack of clarity in protocols and communication standards in the health industry coupled with unfavorable government mandates can act as a hindrance to the growth of the global market for wearable sensors.
Global Wearable Sensors Market – Segments
The market can be segmented into four key dynamics for enhanced understanding;
By Types                   : Comprises Medical Based Sensors, Motion Sensors, Image Sensors, Pressure Sensors, Position Sensors, and Inertial Sensors among others.
By Applications     : Smart Glasses, Smart Wristwear, Smart Bodywears, Smart Footwear and Other Wearable Devices among others.
By End-Users          : Healthcare, Consumer, Enterprises and Industrial among others.
By Regions              : Europe, North America, APAC and Rest-of-the-World.


 Global Wearable Sensors Market – Regional Analysis
The North American region is believed to be the largest market for wearable sensors. The region holds a significant share in the global wearable sensors market and is expected to a create a large revenue pocket by 2020.
The wearable sensors market in the European region stands the second position, growing continuously.
The Asia Pacific region is rapidly emerging as a promising market for wearable sensors. The increasing adoption of smart and connected wearable devices in some of the Asian countries such as Japan, South Korea, China and India is fostering the market growth in the region. Due to increase of internet of things (IoT), the demand of wearable sensors is increasing in various application areas such as healthcare and fitness, consumer electronics and others.
On the other hand, the wearable sensors market in the Rest-of-the-World is likely to witness a limited but steady growth.

Global Wearable Sensors Market   - Competitive Analysis
The well-established wearable sensors market appears to be competitive and fragmented owing to the presence of many small & big players forming a competitive landscape. Those players compete based on product features, innovation, quality, cost, and financial stability. They focus on developing their product portfolio with the help of advance technologies so as to gain a competitive advantage and to maintain their position in the market.
Innovation, M&A, and brand reinforcement remain the key trends for leading players. These 
players are investing on internal R&D and, most of all, in acquiring other promising firms. Prominent manufacturers of wearable sensors are targeting to invest more in technology and research and development activities to innovate and improve their existing product line. The rising government funding is motivating key companies to manufacture new sensors that match the changing trends and needs of the customers.
Key Players:
Some of the eminent leaders of the market include Panasonic Corporation, InvenSense, Inc., Robert Bosch GmbH, Texas Instruments Incorporated, STMicroelectronics, KIONIX, INC. (ROHM Co., Ltd.), Analog Devices, Inc., Measurement Specialties, Inc., ZOLL Medical Corporation (Asahi Kasei Corporation), Infineon Technologies AG., and Freescale Semiconductor, Inc.
Industry/ Innovation/ Related News:
November 02, 2018 –- Cardiac Insight, Inc. (US), a leading global provider of wearable cardiac biosensors and clinical diagnostic software systems announced its partnership with VivoSense (US), leading company focused on integration and specialised analysis of wearable sensor data for research and clinical trials.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312


Posted by at No comments:
Labels: , , , ,

Prostate cancer Market Rising Healthcare Expenditure In Emerging Regions And Developed Economies!!

Prostate Cancer Market study with Detailed Review, Portraying about the Product/Industry Scope and Expounds Industry Outlook and status to 2027.

Global Prostate cancer Market – Overview
The global prostate cancer market is showing the steady growth; mainly owing to increase in patient population. According to report published by Centers for Disease Control and Prevention, in 2014, there were around 172,258 men in the United States, who diagnosed with prostate cancer and around 28,343 men died from prostate cancer. These rising number of prostate cancer create an opportunity for the player to introduce innovative treatment option.


Companies are continuously invent new treatment to capture the global market. Thus players invest more in research and development activities. In this regards, Bayer Pharma AG announced that they have many drugs for the treatment of prostate cancer in there pipeline such as Radium-223 dichloride and BAY 1841788 (ODM-201, AR antagonist).
Progenics Pharmaceuticals, Inc., 2015, acquired Exini Diagnostics AB in order to support its imaging and therapeutic agents with sophisticated analytical tools and other technologies to help patients and physicians understand, target and treat prostate cancer. These companies are more investing in research and development program to provide the best treatment option, which help them to keep ahead with their competitor.
These acquisitions help companies to provide better treatment opportunity in the market and hence improve the quality of life for the people around the world. Additionally it help market players in translating breakthrough science into innovative treatment to help people with prostate cancer worldwide.

Competitive Analysis
Some of the noteworthy players in the global prostate cancer market include Progenics Pharmaceuticals, Inc. (US), Endo Pharmaceuticals Inc. (Ireland), Bayer Pharma AG (Berlin), OncoGenex Pharmaceuticals Inc. (US), OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), and others.
January 30th, 2019, Researchers at the Medical University of South Carolina revealed the successful completion of the world’s first-ever prostate cancer surgery by using Blu Build Cesium-131 brachytherapy delivery system.
February 15th, 2019, Bayer partnering with Orion revealed the numbers showcasing the efficacy of their drug, darolutamide. The report revealed that the drug helped curb down the risk of metastasis or even death by a striking 59% in patients with non-metastatic castration-resistant prostate cancer.
Prostate Cancer Market - Segmentation
The global prostate cancer market segmentation is done on the basis of end-users and product type.
By product type, the market includes hormone therapy, targeted therapies, therapeutic vaccines, and others.
By end-users, the market segments into clinics, hospitals, and others.


Regional Analysis
The regional segmentation of the global prostate cancer market is spearheaded by North America and includes other notable regions like Europe, Asia-Pacific, and Middle East & Africa.
North Americas’ dominant standing in the market is expected to grow further during the forecast period. This can be credited primarily due to the high obesity population. This has prompted the government to be more focused on research and development activities, thereby bringing forward the best treatment facilities for the affected population.
Europe is another huge market for prostate cancer because of the huge existing population affected by this condition. Well-developed treatment facilities, the presence of major market players, and the government’s repeated effort in spreading awareness and educating the population about prostate cancer are all important drivers of the market. 
Asia-Pacific is another region expected to grow during the review period due to the presence of a huge population being affected with the condition. Highly populated countries in this region, India and China, have a huge obesity population, which can potentially lead to incidences of prostate cancer.
Plus, these countries are willing to adopt new technologies and treatment options from developed countries. This is pushing the market growth herein. The Middle East and Africa region boast the least growth potential among all the mentioned regions.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for Asia Pacific, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Friday 24 May 2019

High Throughput Screening Market Synopsis and Highlights, Key Findings, Major Companies Analysis and Forecast to 2023

The report gives detail analysis of the market structure along with forecast, market size & share, different segments and developing trends of the industry.
High Throughput Screening Market – Highlights
High throughput screening (HTS) is a drug discovery process generally utilized in the pharmaceutical companies to influence the mechanization that can rapidly examine the natural or biochemical action of an expansive number of medications.
Since HTS allows assaying of a large number of potential biological modulators against a chosen set of defined targets, it has acquired the status of a popular approach to the target validation.
Over the past few years, the HTS market is growing pervasively mainly due to the burgeoning pharmaceutical industry and the widening adoption of the HTS in the drug discovery. 
Furthermore, the increasing per capita health care expenditures, backed by the improving economic conditions, worldwide, are escalating the market on the ascended heights, increasing the demand for the quality healthcare treatments.
According to a recent study report published by Market Research Future (MRFR), the global market for high throughput screening is expected to grow at a significant rate of CAGR during 2017 – 2027 (forecast period); valuing extravagantly over its previous growth records by the end of the forecast period.
Soaring Investments in the healthcare sector and the shift towards high throughput research propels the growth of the global high throughput screening market. The market is largely driven by target identification & validation, efficacy & safety screening, and monitoring of cell-based activity.
Additional factors supporting the market growth include the huge uptake of open innovation models by pharmaceutical companies, substantiating the use of high-throughput screening, rising drug discovery initiatives by academic and government institutions, boosting the demand for HTS products, and increasing capital investments in high-throughput screening technology by major firms
High Throughput Screening Market – Prominent Players
Aurora Biomed Inc. (Canada)
Beckman Coulter, Inc. (US)
Agilent Technologies Inc. (US)
Life Technologies Corporation (US)
Luminex Corporation (US)
Roche (Switzerland)
Sigma-Aldrich Corporation. (US)
Bio-Rad Laboratories (US)
Thermo Fisher Scientific, Inc. (US)
And others.
The MRFR analysis is segmented into four key dynamics for the convenience of understanding;
By Product Type    :  Software, Instruments, and Consumables among others. 
By Application       :  Target Identification, Primary Screening, Toxicology, and Stem Cell Biology, among others.
By End-user             :  Hospitals, Clinics, Pharmaceutical Companies/ Manufacturers, Government Organizations, and Research Facilities among others.
Global High Throughput Screening Market – Geographical Analysis

Globally, the North America region is the largest market for high throughput screening. Owing to the demanding research and development initiatives, the market is expected to grow at a significant rate of CAGR throughout the forecast period, creating a large revenue pocket by 2027. Factors substantiating the market growth include high healthcare expenditures and substantial investments in the R&D activities for medicine discovery.
Europe accounts for the second-largest market for high throughput screening which is expected to grow at a considerable CAGR during the forecast period. Favorable government support and initiatives drive the growth in the market extensively. The rapidly growing pharmaceutical sector in the region, backed by the resurging economy is fostering the market growth brilliantly. 
Whereas, the Asia Pacific HTS market is growing rapidly, emerging as one of the lucrative markets, globally. Countries in the Asian region especially provide immense growth opportunities for the high-throughput screening market, accounting over half of the world’s total population. Furthermore, private equity firms and venture capitalists are increasingly investing in the HTS market in countries such as India, China, and Japan.
GET MORE INFORMATION:
About Us: 
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us: 
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,

Kidney Dialysis Equipment Market: Observe Strong Development and Impact of Digital Transformation on the Industry by 2023


Kidney Dialysis Equipment Market - Overview
The Global Kidney Dialysis Equipment Market is touted to accumulate USD 16.5 billion at a stupendous 5.7% CAGR during the assessment period (2018-2023). CKD or chronic kidney disease is a chronic condition which seriously impacts a patient’s quality of life.
Kidney dialysis is the most preferred treatment for severe conditions where both the kidneys of a person is damaged but this treatment is also occasionally used for treating patients with a single damaged kidney.
Every day, the kidney of a healthy person filters about 150 quarts of blood. Should an individual’s kidney fail to function efficiently automatically the waste will get collected in the blood resulting in coma and even death.
Here dialysis will act as the savior. It will stop the toxin and waste products formation in the blood. It is an artificial kidney that is used for filtering the blood of the patient during kidney failure, kidney dysfunction and kidney damage and for removing surplus impurities from kidneys.
FREE SAMPLE COPY OF “Kidney Dialysis Equipment Market Research Report – Forecast to 2023” @ https://www.marketresearchfuture.com/sample_request/6302

There are many factors that is driving the growth of the kidney dialysis equipment market. Some of these factors as per the Market Research Future (MRFR) report include new funding channels in the healthcare sector, increase in the prevalence of dialysis patients, better healthcare infrastructure, adoption of latest technologies in dialysis, loss of appetite causing weight loss, change in sedentary lifestyle, heart failure, growing acidosis, growing number of ESRD (End Stage Renal Disease Patients), increase in accurate and cost-effective portable dialysis apparatus, fast growth in geriatric population, growing frequencies of hypertension and diabetes problems and preference for dialysis over kidney transplantation.
On the contrary, factors such as difficulties and risks involved, time consumption, regulations and rules associated with dialysis, expensive treatments and soaring cost of dialysis procedures may take a toll on the growth of the kidney dialysis equipment market over the assessment period.
Leading Key Players
Leading players profiled in the kidney dialysis equipment market include Hemoclean CO., LTD, Teleflex Incorporated, Rockwell Medical, Terumo Corporation, Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation), Mar Cor Purification, Inc. (A Cantel Medical Company), Nikkiso Co., Ltd., Nxstage Medical, Inc., Nipro Corporation, Diaverum Deutschland GmbH, B. Braun Melsungen AG, Baxter International Inc., Davita Healthcare Partners Inc and Fresenius Medical Care AG & Co. Ka.
Feb 2019- Leading dialysis service provider, US Renal Care, Inc will be acquired by Investor Group with an aim to improve the quality of life for those having chronic renal disease.
April 2018- MRCS (Malaysian Red Crescent Society) and KDC (Kidney Dialysis Centre) off late has received accolades for their success to help countless patients in the last 22 years.
Market Segmentation
Market Research Future report offers an all-inclusive segmental analysis of the kidney dialysis equipment market on the basis of type, apparatus type and end-user.
Based on type, it is segmented into Continuous Renal Replacement Therapy (CRRT), peritoneal dialysis and hemodialysis. Hemodialysis is further segmented into nocturnal hemodialysis, short daily hemodialysis and conventional hemodialysis.
The Peritoneal dialysis is further segmented into Tidal Peritoneal Dialysis, Intermittent Peritoneal Dialysis (IPD), Continuous Cycling Peritoneal Dialysis (CCPD) and Continuous Ambulatory Peritoneal Dialysis (CAPD).
Based on apparatus type, the kidney dialysis equipment market is segmented into consumables and continuous renal replacement therapy systems, peritoneal dialysis equipment and hemodialysis equipment. The hemodialysis equipment we further segmented into vascular access devices, tunneled hemodialysis catheters, concentrates and solutions, bloodline system, dialyzers and filters and hemodialysis machine.
The peritoneal dialysis equipment is segmented into filters, dialyzers, automated peritoneal dialysis machines and concentrates and solutions. Of these, the hemodialysis equipment will grab the maximum market share.
Based on end-user, the kidney dialysis equipment market is segmented into ambulatory services, home care, in-center dialysis settings and hospitals.
OBTAIN PREMIUM RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/kidney-dialysis-equipment-market-6302
Kidney Dialysis Equipment - Regional Analysis
Based on region, the kidney dialysis equipment market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America is likely to command the market owing to the rising incidence of kidney failure, rising cases of diabetes and hypertension and higher reusable income amid people.
Europe will have the second biggest share due to advanced medical compensation and progressive organizations.
The kidney dialysis equipment market in APAC possess an unprecedented market potential owing to increasing incidences of kidney failure, increase in disposable income, presence of large geriatric population and low rates of organ transplantation. The kidney dialysis equipment market in the Middle East and Africa will have minimal share owing to low per capita income and stringent government policies.
About Us:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels: , ,

Thursday 23 May 2019

TMJ Implants Market Trends, Share, Growth Drivers and Forecast by 2023


Market Highlights
The TMJ Implants market is expected to grow due to factors such as increasing beauty consciousness towards anatomical deformities such as malocclusion, the presence of compressed bone in ramus of mandible, or avascular necrosis or fractures due to accidents. Furthermore, the increasing number of geriatric population, advancement of medical devices, as well as availability of skilled professionals and governmental initiatives to support healthcare reforms are spurring the market growth.


However, high capital investments required for joint replacement orthodontic surgeries, cost of these implants, and infection rates associated with the implants are restricting the market growth. Unavailability of skilled professionals as well as lack of proper healthcare infrastructure in middle-income countries are major challenges faced by this growing market.

Regional Analysis
Americas is going to hold the largest share for TMJ implants market owing to increase the inclination of youth towards beauty industry, accessibility to advanced surgeries, availability of good healthcare infrastructure and rising per capita income of people. For instance, according to the survey conducted by American Association of Orthodontists in the year 2014, there was 16% increase in the number of adults seeking orthodontic care from U.S. and Canada and 75% of respondents surveyed reported improvements in career and personal relationships post-orthodontic treatment due to their improved smile. Furthermore, rising geriatric population can lead to increase in degenerated or resorbed mandibular joints issue, and rising road accidents can lead to fractures in TMJ joints, thus leading to increase in the patient pool which will fuel up the market growth during the forecast period.
Europe is the second market leader and holds a healthy share in the global TMJ Implants market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the flourishing medical device market, the presence of orthodontic surgeons, good healthcare infrastructure, and favorable reimbursement policies. For instance, according to cancer research U.K., there were around 9, 921 cases of cancer diagnosed in 2015. Lung cancer and oral cancer can lead to condylar metastasis and avascular necrosis of TMJ joints which may further risk TMJ joint dislocation. So, the rising incidence of cancer can boost up the market growth of TMJ implants in Europe.
Asia Pacific is expected to show promising growth and be the fastest emerging market. According to report published by the United Nations in 2015, 66% of world’s geriatric population is going to reside in the Asia-Pacific region which would fuel up the number of TMJ implants surgery due to increase in degenerated or resorbed mandibular joints issue. Furthermore, government initiatives for healthcare reform, availability of favorable reimbursement policies & health insurances, improvement in healthcare infrastructure is driving the market growth. Similarly, due to a higher occurrence of lung cancer and oral cancer in Asia, chances of condylar metastasis and TMJ dissociation associated with it are higher which may boost up the market growth.
The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia are the largest market share owing to the development of the healthcare industry and rising availability of specialty care centers.


Segmentation
The global TMJ implants market is segmented on the basis of product type, material, application, and end-users. Considering product type, the market is segmented into mandibular component, fossa component, screws, and instruments. Instruments are further segmented into TMJ flat diamond rasp, TMJ diamond burrs, TMJ double-ended drill guide, and retractors. By material, the market is segmented into cobalt-chromium-molybdenum, ultra-high molecular weight polyethylene, titanium alloy, aluminum, silicone, others. With reference to application, the market is segmented into TMJ arthroscopy, orthognathic surgery, discectomy and disc repair procedures, total joint replacement and others. On account of end-users, the market is segmented into hospitals, dental clinics, research and academics, and others.
Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Key Players
Market Research Future (MRFR) recognizes the following companies as the key players in the TMJ Implants market. Some of the players are Ortho Baltic, Zimmer, TMJ Medical, TMJ Concepts, TKarl Storz , Xilloc Medical B.V and Dow Corning.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Tuesday 21 May 2019

Substance Abuse Treatment Market Shares Analysis, Key Development Strategies and Forecasts Till 2023

Market Highlights
The Global substance abuse treatment market is expected to grow at an approximate CAGR of 11.6% during forecast period, 2018–2023.
Increasing cases of tobacco smoking is one of the prominent factors driving the substance abuse treatment market. According to the information published in the Frontiers in Psychiatry journal, China is facing an immense public health challenge from tobacco smoking. It is estimated that number of deaths, due to cigarette smoking, will reach 2 million by 2030 and 3 million by 2050.


Various other factors such as increasing incidence of drug addiction, technological advancement in the diagnostics industry, rising patient awareness about substance abuse treatment and improvement in treatment rates and healthcare infrastructure are also expected to propel the growth of the market.
However, poor treatment compliance in some countries and reluctance of individuals for accessing treatment can hamper the market growth over the forecast period.

Segmentation
The Global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.
The Global market for substance abuse treatment, by abuse type is segmented into alcohol dependence, tobacco/nicotine addiction, and drug abuse. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid.
The market, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified as disulfiram, acamprosate, and naltrexone. The tobacco/nicotine addiction treatment segment is further classified as nicotine replacement treatment, and non-nicotine medication. The nicotine replacement treatment segment includes nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.
Based on end user, the market is segmented into outpatient treatment centres, residential treatment centres, and inpatient treatment centres.

Regional Analysis
The Americas dominated the global market for substance abuse treatment owing to presence of major market players and rising awareness about substance abuse treatment within the region. In recent years, various private and government organizations have launched campaigns and seminar to spread awareness about substance abuse. For instance, in February 2017, the Ad Council and Viacom have launched the LISTEN campaign and a new PSA to address America’s substance abuse crisis.
In 2017, it was estimated that Europe stood second in the global substance abuse treatment market. This can be attributed to the rising research and development investments.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as increasing incidences of tobacco addiction and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region.

Key Players
Some of the key players in the global substance abuse treatment market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., Purdue Pharma LP, Allergan, Mylan Laboratories, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceuticals, Forest Laboratories, Inc., Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharmaceuticals, and others.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Global Gastritis Treatment Market Had a Significant Effect on Global Industry Forecast to 2023

Market Highlights
The gastritis treatment market is expected to exhibit a robust growth rate during the forecast period. The market for gastritis treatment is expanding worldwide due to drivers such as increased incidence of acute and chronic gastritis, advances in the area of medical technologies, increasing fast food chains worldwide, massive adoption of sedentary lifestyle and advancement in endoscopy devices that increased the accuracy of diagnosis. Moreover, chronic gastritis patients, rely on acidity reducing medicines for a lifetime,  thus fueling the market demand which in turn would boost up the market growth. However, unaffordability and lack of advanced medical device technology in middle-income countries are likely to hamper the market growth.
Regional Analysis
The Americas is going to account for the largest share for gastritis treatment market. Drivers such as the widespread of fast food chains in this region along with increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market. Moreover, rising alcohol abuse, the presence of prominent key players is likely to spur the market growth.  For instance, According to a published survey, approximately 1 in 100 is a victim of gastritis in the US. Thus, this increasing patient pool will enhance the market growth during the forecasted period. Additionally, factors such as increasing government initiatives and funding for research, development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of gastritis treatment market in the American region. Furthermore, according to CMS (Centers for Medicare and Medicaid Services) the US health care spending increased 4.3 percent to reach USD 3.3 trillion per person in 2016. Thus, the increasing per capita income of individuals, as well as rising healthcare spending, will aid the upmarket growth of the Americas.
Europe is the second market leader and holds a healthy share in the global gastritis treatment market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities, established healthcare infrastructure along with the presence of flourishing medical device market which helps in efficient and accurate diagnosis. Furthermore, due to the increasing number of lactose-intolerant issues, vulnerability to falling prey of gastritis is more likely to lead to an increasing number of gastritis sufferers. Thus, fueling the market growth during the forecast period.
Asia-Pacific is expected to be the fastest emerging market owing to increasing government initiatives for healthcare reform, increasing adaption of a sedentary lifestyle, and increasing prevalence of gastritis. Moreover, the prevalence of multifocal atrophic gastritis and gastric adenocarcinomas is high in these regions. Furthermore, the presence of renowned domestic pharmaceutical players, as well as the increasing healthcare spending per capita, is going to accelerate the market growth during the forecast period.
The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of the healthcare industry, increasing occurrence of gastritis and sound economic status of inhabitants.
Segmentation
The global gastritis treatment market is segmented on the basis of diagnosis, treatment type, drug distribution channel, and end-users.
Considering the diagnosis, the market is segmented into blood test, endoscopy, x-ray of the upper digestive system and others.
By treatment type, the market is segmented into acid-blocking medicines, antibiotics, antacids, and histamine blockers.
With reference to the drug distribution channel, the market is segmented into retail pharmacy, online pharmacy, and hospital pharmacy.
On account of end-users, the market is segmented into hospitals and clinics and others.
Based on region the market is segmented into the Americas, Europe, Asia-Pacific, and Middle East and Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Key Players
Market Research Future (MRFR) recognizes the following companies as the key players in the global gastritis treatment market. Some of the players are Abbott Laboratories, AstraZeneca PLC, Novartis AG, Microbiotix, Inc, Dr. Reddy’s Laboratories, Lupin Ltd, Perrigo Pharmaceutical, Cipla Inc., Pfizer Inc., and SUN Pharmaceuticals Industries limited.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)